Page last updated: 2024-09-04

n(6)-benzyl-cyclic adenosine 5'-monophosphate and metallothionein

n(6)-benzyl-cyclic adenosine 5'-monophosphate has been researched along with metallothionein in 1 studies

Compound Research Comparison

Studies
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Trials
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Recent Studies (post-2010)
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Studies
(metallothionein)
Trials
(metallothionein)
Recent Studies (post-2010) (metallothionein)
5019,390412,223

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Budillon, A; Cho-Chung, YS; Clair, T; Merlo, G; Pepe, S; Rohlff, C; Tortora, G; Yokozaki, H1

Other Studies

1 other study(ies) available for n(6)-benzyl-cyclic adenosine 5'-monophosphate and metallothionein

ArticleYear
Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1994, Volume: 5, Issue:7

    Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Allosteric Site; Animals; Cadmium; Cell Differentiation; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Metallothionein; Mice; Phenotype; Promoter Regions, Genetic; Recombinant Fusion Proteins; Retroviridae; Signal Transduction; Tumor Cells, Cultured

1994